补骨脂酚通过激活ROS强化TRAIL的抗肝细胞癌HepG2细胞作用的机制研究  被引量:3

Bakuchiol Enhanced TRAIL Induced HepG2 Cell Apoptosis through Activating Oxidative Stress

在线阅读下载全文

作  者:肖嘎 杨锐 吴涛[3] 党玲 宋涛[1] 董昌利 XIAO Ga;YANG Ru;WU Tao;DANG Ling;SONG Tao;DONG Chang-li(Department of General Surgery,Second Affliated Hospital of Xi'an Medical College,Xi'an,Shaanxi,710038,China;Internal Medicine Departmeng Gucheng People's Hospital,Hengshui,Hebei,253800,China;Department of General Surgery,Tangdu Hospital,Fourth military medical university,Xi'un,Shaanxi,710038,China)

机构地区:[1]西安医学院第二附属医院普外科,陕西西安710038 [2]故城县医院内五科,河北衡水253800 [3]第四军医大学附属唐都医院普外科,陕西西安710038

出  处:《现代生物医学进展》2018年第20期3835-3839,3853,共6页Progress in Modern Biomedicine

基  金:陕西省科学技术研究发展计划项目(2013K12-03-06)

摘  要:目的:探究补骨脂酚(Bakuchiol,Bak)对肿瘤坏死因子相关凋亡诱导配体(Tumor necrosis factor-related apoptosis-inducing ligand,TRAIL)抗HepG2细胞作用的影响及内在机制。方法:常规培养HepG2细胞,给予梯度浓度的Bak处理,检测细胞活力。联合应用Bak与TRAIL处理,检测细胞活力。Western blot检测Bak处理后氧化应激水平、死亡受体4(Death Receptor 4,DR4)、DR5的表达变化。联合应用Bak与TRAIL检测凋亡情况。进而引入ROS清除剂NAC,联合NAC处理后,检测ROS、DR4、DR5以及凋亡情况。结果:Bak剂量依赖地抑制了HepG2细胞的活力,联合应用Bak+TRAIL对细胞活力的抑制作用优于单独用药。Bak处理后氧化应激水平升高,体现在ROS增加,GSH水平下降;Western blot检测发现Bak处理后DR4、DR5表达增加。联合应用Bak+TRAIL显著增加了细胞凋亡蛋白Bax的表达,抑制了抗凋亡蛋白Bcl2的表达。引入ROS阻断剂NAC处理后,与Bak+TRAIL组相比,ROS水平下降,DR4、DR5表达减少。凋亡检测发现NAC处理降低了Bak+TRAIL引起的细胞凋亡。结论:Bak可以显著增强TRAIL引起的HepG2细胞凋亡,该作用可能与Bak激活氧化应激进而上调DR4、DR5表达有关。Objective: To investigate the roles of Bakuchiol(Bak) on HepG2 cell and the effects of co-treatment of Bak and Tumor necrosis factor-related apoptosis-inducing ligand(TRAIL) on HepG2 cells, as well as the inner mechanisms. Methods: Cells were treated with different concentrations of Bak or Bak+TRAILand cell vitality was detected 24 h later. After Bak treatment, cell oxidative stress levels were examined through DCF-DA staining and ROS, GSH detection. Western blot analysis was conducted to detected the expressions of Death receptor 4(DR4) and DR5. After Bak+TRAIL treatment, cell apoptosis status was detected. Furthermore, ROS scavenger NAC was used to inhibit oxidative stress and DR4, DR5, Bax expressions were detected. Results: Both Bak and TRAIL can reduce HepG2 cell vitality. Co-treatment of Bak and TRAIL further reduced the cell vitality. Bak treatment increased ROS production,DR expressions and reduced cellular GSH level. Co-treatment of Bak and TRAIL induced higher level of apoptosis compared with single-drug treatment. Compared with the Bak + TRAIL group, NAC treatment reduced ROS level and reduced DR expression, as well as the Bak+TRAIL induced apoptosis levels. Conclusion: Bak enhances TRIAL induced HepG2 cell apoptosis and tumor growth via activating cellular oxidative stress and up regulating DR4 and DR5 expressions.

关 键 词:肝细胞肝癌 补骨脂酚 肿瘤坏死因子相关凋亡诱导配体 氧化应激 死亡受体 

分 类 号:R-33[医药卫生] F735.7[经济管理—产业经济]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象